Siemens Healthineers to speculate Rs 1,300 cr in India innovation hub

Global med-tech firm Healthineers on Tuesday stated it plans to speculate Rs 1,300 crore over the following 5 years in an hub in Bengaluru.

The funding goals to make India a producing centre for the corporate’s rising market merchandise.

The hub might be housed in a brand new campus that may mix R&D and manufacturing to make India a centre of competence for the design and improvement of entry-level merchandise, stated the corporate headquartered in Erlangen, Germany.

Healthineers stated it plans to rent a further 1,800 expert digital tech specialists to develop its digital capabilities within the subsequent 10 years.

“This investment is the largest we have ever made in India. It will play a key role in taking our business to the next level by driving digitalisation and expanding our portfolio for emerging markets,” Elisabeth Staudinger, President Asia Pacific, Healthineers, stated in an announcement.

“The hub in Bengaluru will show our dedication to advance by leading edge digital applied sciences in addition to by accessible and inexpensive improvements pushed from India.”

When accomplished in 2025, the primary part of the brand new campus will embrace 70,000 sq. meters of workplace area for the enlarged R&D centre and 5,000 sq. metres of manufacturing facility area, the corporate stated.

The Bengaluru campus might be one among 4 innovation hubs of the corporate, with the opposite hubs situated within the US, Germany, and China.

The innovation hub at Bengaluru will embrace centres of competence in digital applied sciences comparable to information analytics, Artificial Intelligence (AI), immersive applied sciences like augmented and digital actuality, person expertise, and cybersecurity.

Siemens Healthineers stated it has already invested about Rs 2,500 crore in R&D in India.

With about 50 per cent of all of the software program engineers in Siemens Healthineers, the prevailing R&D centre at Bengaluru performs a strategic function in growing leading edge software program merchandise and platforms for all three segments of the corporate — imaging, diagnostics, and superior therapies.



(Only the headline and movie of this report could have been reworked by the Business Standard workers; the remainder of the content material is auto-generated from a syndicated feed.)

Table of Contents

Dear Reader,

Business Standard has all the time strived arduous to offer up-to-date data and commentary on developments which might be of curiosity to you and have wider political and financial implications for the nation and the world. Your encouragement and fixed suggestions on how one can enhance our providing have solely made our resolve and dedication to those beliefs stronger. Even throughout these tough occasions arising out of Covid-19, we proceed to stay dedicated to preserving you knowledgeable and up to date with credible information, authoritative views and incisive commentary on topical problems with relevance.

We, nonetheless, have a request.

As we battle the financial impression of the pandemic, we’d like your assist much more, in order that we are able to proceed to give you extra high quality content material. Our subscription mannequin has seen an encouraging response from lots of you, who’ve subscribed to our on-line content material. More subscription to our on-line content material can solely assist us obtain the objectives of providing you even higher and extra related content material. We consider in free, honest and credible journalism. Your assist by extra subscriptions might help us practise the journalism to which we’re dedicated.

Support high quality journalism and subscribe to Business Standard.

Digital Editor


Please enter your comment!
Please enter your name here